LABD vs. ARKK
LABD (Direxion Daily S&P Biotech Bear 3x Shares) and ARKK (ARK Innovation ETF) are both exchange-traded funds - LABD is a Leveraged Equities fund tracking the S&P Biotechnology Select Industry Index (-300%), while ARKK is a Technology Equities fund actively managed by ARK. LABD is passively managed, while ARKK is actively managed. Over the past 10 years, LABD returned -58.05%/yr vs 15.01%/yr for ARKK. At a correlation of -0.71, they often move in opposite directions. LABD charges 1.06%/yr vs 0.75%/yr for ARKK.
Performance
LABD vs. ARKK - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, LABD achieves a -58.72% return, which is significantly lower than ARKK's -0.33% return. Over the past 10 years, LABD has underperformed ARKK with an annualized return of -58.05%, while ARKK has yielded a comparatively higher 15.01% annualized return.
LABD
- 1D
- 8.60%
- 1M
- -31.85%
- 6M
- -55.64%
- YTD
- -58.72%
- 1Y
- -85.70%
- 3Y*
- -58.22%
- 5Y*
- -47.09%
- 10Y*
- -58.05%
ARKK
- 1D
- -3.68%
- 1M
- -3.05%
- 6M
- -6.42%
- YTD
- -0.33%
- 1Y
- 1.89%
- 3Y*
- 15.88%
- 5Y*
- -7.78%
- 10Y*
- 15.01%
LABD vs. ARKK - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
LABD Direxion Daily S&P Biotech Bear 3x Shares | -58.72% | -70.07% | -21.43% | -41.77% | -32.68% | 1.86% | -89.75% | -70.80% | -6.26% | -75.67% |
ARKK ARK Innovation ETF | -0.33% | 35.49% | 8.40% | 69.04% | -66.97% | -23.60% | 152.71% | 35.08% | 3.52% | 87.33% |
Correlation
The correlation between LABD and ARKK is -0.54, meaning they tend to move in opposite directions. This is especially valuable for risk management - when one declines, the other has historically tended to hold steady or rise.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | -0.54 |
Correlation (3Y) Calculated over the trailing 3-year period | -0.63 |
Correlation (5Y) Calculated over the trailing 5-year period | -0.71 |
Correlation (10Y) Calculated over the trailing 10-year period | -0.72 |
Correlation (All Time) Calculated using the full available price history since May 28, 2015 | -0.71 |
The correlation between LABD and ARKK shifts across timeframes, from -0.72 (10 years) to -0.54 (1 year), reflecting how their relationship changes across market environments.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
LABD vs. ARKK — Risk / Return Rank
LABD
ARKK
LABD vs. ARKK - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Direxion Daily S&P Biotech Bear 3x Shares (LABD) and ARK Innovation ETF (ARKK). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| LABD | ARKK | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.14 | ||
| Sortino ratioReturn per unit of downside risk | -2.92 | ||
| Omega ratioGain probability vs. loss probability | 0.72 | 1.04 | -0.32 |
| Calmar ratioReturn relative to maximum drawdown | -0.96 | 0.06 | -1.02 |
| Martin ratioReturn relative to average drawdown | -1.33 | 0.13 | -1.45 |
Loading charts...
Drawdowns
LABD vs. ARKK - Drawdown Comparison
The maximum LABD drawdown since its inception was -100.00%, which is greater than ARKK's maximum drawdown of -80.97%. Use the drawdown chart below to compare losses from any high point for LABD and ARKK.
Loading charts...
Drawdown Indicators
| LABD | ARKK | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -100.00% | -80.97% | -19.03% |
Max Drawdown (1Y)Largest decline over 1 year | -89.59% | -31.35% | -58.24% |
Max Drawdown (3Y)Largest decline over 3 years | -97.43% | -39.56% | -57.87% |
Max Drawdown (5Y)Largest decline over 5 years | -99.04% | -76.27% | -22.77% |
Max Drawdown (10Y)Largest decline over 10 years | -99.99% | -80.97% | -19.02% |
Current DrawdownCurrent decline from peak | -99.99% | -50.35% | -49.64% |
Average DrawdownAverage peak-to-trough decline | -91.04% | -30.30% | -60.74% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 64.54% | 14.99% | +49.55% |
Volatility
LABD vs. ARKK - Volatility Comparison
Direxion Daily S&P Biotech Bear 3x Shares (LABD) has a higher volatility of 25.77% compared to ARK Innovation ETF (ARKK) at 9.07%. This indicates that LABD's price experiences larger fluctuations and is considered to be riskier than ARKK based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| LABD | ARKK | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 25.77% | 9.07% | +16.70% |
Volatility (6M)Calculated over the trailing 6-month period | 65.70% | 27.12% | +38.58% |
Volatility (1Y)Calculated over the trailing 1-year period | 79.35% | 36.49% | +42.86% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 96.77% | 46.50% | +50.27% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 95.75% | 40.42% | +55.33% |
LABD vs. ARKK - Expense Ratio Comparison
LABD has a 1.06% expense ratio, which is higher than ARKK's 0.75% expense ratio.
Dividends
LABD vs. ARKK - Dividend Comparison
LABD's dividend yield for the trailing twelve months is around 7.61%, while ARKK has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
ARKK ARK Innovation ETF | 0.00% | 0.00% | 0.00% | 0.70% | 0.00% | 0.55% | 1.64% | 0.38% | 3.14% | 1.32% | 0.00% | 2.27% |
LABD Direxion Daily S&P Biotech Bear 3x Shares | 7.61% | 6.67% | 4.68% | 6.13% | 0.53% | 0.00% | 3.94% | 1.75% | 0.81% | 0.00% | 0.00% | 0.00% |
Frequently Asked Questions
LABD and ARKK have a correlation of -0.54, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
LABD has higher volatility (25.77%) compared to ARKK (9.07%). In terms of maximum drawdown, LABD dropped -100.00% vs ARKK's -80.97%.
On 10-year performance, ARKK leads with 15.01% vs -58.05% for LABD. On fees, ARKK is cheaper at 0.75% per year. On volatility, ARKK has been the lower-risk option at 9.07%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 10-year period, ARKK has performed better with a 15.01% return vs -58.05%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
ARKK is cheaper with a 0.75% expense ratio, compared with 1.06% for LABD.
LABD has the higher dividend yield at 7.61%, compared with 0.00% for ARKK.
LABD is categorized as Leveraged Equities, while ARKK is Technology Equities. They also come from different issuers: Direxion and ARK. Their fees differ too: 1.06% for LABD and 0.75% for ARKK.
ARKK currently has the higher Sharpe Ratio (0.05 vs -1.08), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for LABD and ARKK
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer